Summary

This article discusses the relationship between glucagon-like peptide-1 (GLP-1) and both cardiovascular disease, as well as the central nervous system.

  • Hyperglycemia/Hypoglycemia
  • Obesity
  • Diabetes Mellitus Diabetes & Metabolic Syndrome
View Full Text